SCHEMBL1035487

SCHEMBL1035487

Cc1c(OC(N)=O)sc2nc(-c3ccc(F)cc3)cn12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.54
TP53 P04637 6/20 0.53
LMNA P02545 6/20 0.53
HSD17B10 Q99714 4/20 0.53
HPGD P15428 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
KDM4E B2RXH2 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
THRB P10828 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
TSHR P16473 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
USP2 O75604 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CASP1 P29466 1/20 0.51
PPARG P37231 1/20 0.51
NCOA2 Q15596 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034966 0.90 LMNA (0.57) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1034956 0.86 TP53 (0.56) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1033367 0.85 LMNA (0.56) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1030953 0.83 NPC1 (0.55) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1036696 0.83 MAPT (0.58) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1034601 0.81 MAPT (0.50) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1035662 0.81 LMNA (0.57) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1034482 0.81 MAPT (0.76) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1035981 0.80 TP53 (0.70) MAPTTP53LMNAHSD17B10HPGD
SCHEMBL1032433 0.78 MAPT (0.51) MAPTTP53LMNAHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2086537-B1 IMIDAZO[2,1-B]THIAZOLES AND THEIR USE AS PHARMACEUTICALS SANOFI AVENTIS (FR) 2011-01-26 EP claimed